Theseus Pharmaceuticals Price Prediction

THRXDelisted Stock  USD 3.71  0.14  3.92%   
At this time, The value of RSI of Theseus Pharmaceuticals' share price is at 56. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Theseus Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

56

 
Oversold
 
Overbought
The successful prediction of Theseus Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Theseus Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Theseus Pharmaceuticals hype-based prediction, you can estimate the value of Theseus Pharmaceuticals from the perspective of Theseus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Theseus Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Theseus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Theseus Pharmaceuticals after-hype prediction price

    
  USD 3.71  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Intrinsic
Valuation
LowRealHigh
3.523.524.08
Details
Naive
Forecast
LowNextHigh
1.891.891.89
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.123.533.93
Details

Theseus Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Theseus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Theseus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Theseus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Theseus Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Theseus Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Theseus Pharmaceuticals' historical news coverage. Theseus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 3.71 and 3.71, respectively. We have considered Theseus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.71
3.71
After-hype Price
3.71
Upside
Theseus Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Theseus Pharmaceuticals is based on 3 months time horizon.

Theseus Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Theseus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Theseus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Theseus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
2 Events / Month
4 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.71
3.71
0.00 
0.00  
Notes

Theseus Pharmaceuticals Hype Timeline

Theseus Pharmaceuticals is at this time traded for 3.71. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Theseus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Theseus Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 3.71. About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Theseus Pharmaceuticals has Price/Earnings (P/E) ratio of 737.67. The entity recorded a loss per share of 1.34. The firm last dividend was issued on the September 8, 2015. Theseus Pharmaceuticals had 1241:1000 split on the June 3, 2014. Given the investment horizon of 90 days the next projected press release will be in a few days.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Theseus Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Theseus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Theseus Pharmaceuticals' future price movements. Getting to know how Theseus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Theseus Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LIFEATyr Pharma 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
RLAYRelay Therapeutics 0.00 0 per month 0.00 (0.08) 4.82 (6.29) 66.18 
IPSCCentury Therapeutics 0.01 9 per month 0.00 (0.11) 6.21 (8.82) 23.66 
BPMCBlueprint Medicines Corp(1.72)8 per month 2.58 (0.02) 4.90 (3.62) 14.28 
PMVPPmv Pharmaceuticals 0.00 0 per month 2.02 (0.03) 3.75 (3.64) 13.98 
CGEMCullinan Oncology LLC 1.25 10 per month 0.00 (0.17) 5.88 (7.24) 17.85 
ELVNEnliven Therapeutics 0.00 0 per month 1.98  0.03  5.84 (4.07) 12.96 
IMRXImmuneering Corp 0.00 0 per month 5.22  0.12  15.50 (8.68) 60.06 
GRCLGracell Biotechnologies 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
GLUEMonte Rosa Therapeutics 0.00 0 per month 4.04  0.06  7.42 (8.18) 102.66 
DSGNDesign Therapeutics 0.00 0 per month 5.40  0.02  8.54 (8.21) 35.31 
ERASErasca Inc 0.06 8 per month 0.00 (0.04) 7.34 (5.38) 17.38 
XFORX4 Pharmaceuticals 0.00 0 per month 0.00 (0.06) 6.90 (10.61) 62.35 
GRTXGalera Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TERNTerns Pharmaceuticals(0.02)10 per month 0.00 (0.1) 5.68 (5.96) 34.09 
DAWNDay One Biopharmaceuticals 0.23 9 per month 0.00 (0.07) 3.84 (3.69) 11.44 
HOOKHookipa Pharma 0.00 0 per month 0.00 (0.37) 4.05 (7.24) 22.98 
MRSNMersana Therapeutics 0.00 0 per month 5.15  0.06  12.03 (9.72) 32.25 
RCUSArcus Biosciences 0.00 0 per month 0.00 (0.12) 4.64 (5.85) 17.22 

Theseus Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Theseus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Theseus using various technical indicators. When you analyze Theseus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Theseus Pharmaceuticals Predictive Indicators

The successful prediction of Theseus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Theseus Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Theseus Pharmaceuticals based on analysis of Theseus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Theseus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Theseus Pharmaceuticals's related companies.

Story Coverage note for Theseus Pharmaceuticals

The number of cover stories for Theseus Pharmaceuticals depends on current market conditions and Theseus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Theseus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Theseus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Theseus Pharmaceuticals Short Properties

Theseus Pharmaceuticals' future price predictability will typically decrease when Theseus Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Theseus Pharmaceuticals often depends not only on the future outlook of the potential Theseus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Theseus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding38.5 M
Cash And Short Term Investments198 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Theseus Stock

If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world